{
  "nct_id": "NCT92902838",
  "indication": "Type 2 Diabetes",
  "phase": "Phase 2/3",
  "sample_size": 733,
  "duration_weeks": 59,
  "dropout_rate": 0.25,
  "blinding": "open-label",
  "control_arm": "no control",
  "primary_endpoints": [
    "HbA1c reduction"
  ],
  "secondary_endpoints": [
    "Fasting glucose reduction",
    "Postprandial glucose reduction"
  ],
  "outcome_summary": "Statistically significant improvement on primary and key secondary endpoints",
  "success": 1,
  "start_date": "2022-09-28",
  "completion_date": "2023-11-15"
}